Drug Discovery

Alpine Immune Sciences to merge with Nivalis Therapeutics

Alpine Immune Sciences has agreed to merge with a subsidiary of Nivalis Therapeutics in an all-stock transaction.

Lyndra secures $23m funding to develop therapeutic oral delivery platform

Lyndra has secured $23m Series A financing, led by Polaris Partners, with participation from Quark Venture and GF Securities, Yonghua Capital, Healthlink Capital, Suffolk Equity, Partners Healthcare among others.

PureTech Health launches new immuno-oncology programme

PureTech Health has launched a new immuno-oncology programme to develop monoclonal antibodies to target newly discovered immunosuppressive mechanisms in pancreatic cancer and other solid tumours.

Accenture, BioCelerate partner to advance biopharmaceutical innovation

Accenture and TransCelerate BioPharma's subsidiary BioCelerate have partnered to advance biopharmaceutical innovation through increased insights in research & development.

Eisai and Meiji enter into agreement for Parkinson’s disease drug in Asian countries

Eisai and Meiji Seika Pharma have entered into a license agreement for the commercialization of safinamide for Parkinson's disease treatment in Japan and Asia.

Sucampo Pharmaceuticals buys rare disease firm Vtesse

Sucampo Pharmaceuticals has acquired rare disease company Vtesse for upfront consideration of $200m.

Verona Pharma announces new collaborations to develop dry powder and MDI formulations for COPD

Verona Pharma has announced new collaborations with two European technology companies to develop its first-in-class product candidate RPL554 as dry powder inhaler (DPI) and metered dose inhaler (MDI) formulations for maintenance treatment of chronic obstructive pulmonary disease (COPD).

Immuno-oncology company Agenus to cut 50 jobs in reorganization

Clinical-stage immuno-oncology firm Agenus is reorganizing its business and operations to straighten its focus on clinical development of its two checkpoint inhibitor antibodies and vaccine program.

Warp Drive Bio forms technology alliance with GSK

Warp Drive Bio has partnered with GSK to discover potential therapeutics in oncology and other diseases.